zolpidem has been researched along with glutamic acid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cunningham, MO; Jones, RS; Woodhall, GL | 1 |
| Antolín, I; Fernández-Marí, F; García-Santos, G; Herrera, F; Martín, V; Rodriguez, C; Rodriguez-Blanco, J | 1 |
| Heikkinen, AE; Korpi, ER; Möykkynen, TP | 1 |
| Jensen, JE; Licata, SC; Lukas, SE; Penetar, DM; Prescot, AP; Renshaw, PF | 1 |
| Clauss, RP | 1 |
| Gulati, S; Kilduff, TS; Mathew, TK; Neylan, TC; Nguyen, AT; Schwartz, MD; Vazquez-DeRose, J; Warrier, DR | 1 |
1 trial(s) available for zolpidem and glutamic acid
| Article | Year |
|---|---|
A therapeutic dose of zolpidem reduces thalamic GABA in healthy volunteers: a proton MRS study at 4 T.
Topics: Administration, Oral; Adult; Brain Chemistry; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Hypnotics and Sedatives; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Pyridines; Single-Blind Method; Surveys and Questionnaires; Thalamus; Zolpidem | 2009 |
6 other study(ies) available for zolpidem and glutamic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Valproate modifies spontaneous excitation and inhibition at cortical synapses in vitro.
Topics: Animals; Anticonvulsants; Cerebral Cortex; Excitatory Postsynaptic Potentials; GABA Agonists; gamma-Aminobutyric Acid; Glutamic Acid; In Vitro Techniques; Male; Membrane Potentials; Patch-Clamp Techniques; Pyridines; Rats; Rats, Wistar; Synapses; Synaptic Transmission; Valproic Acid; Zolpidem | 2003 |
Antioxidant activity and neuroprotective effects of zolpidem and several synthesis intermediates.
Topics: Animals; Antioxidants; Brain; Cell Death; Cells, Cultured; Chromans; Estradiol; Ferrous Compounds; Glutamic Acid; Hippocampus; Lipid Peroxidation; Liver; Male; Melatonin; Neurons; Neuroprotective Agents; Oxidation-Reduction; Oxidative Stress; Proteins; Pyridines; Rats; Reactive Oxygen Species; Structure-Activity Relationship; Zolpidem | 2004 |
Long-lasting modulation of glutamatergic transmission in VTA dopamine neurons after a single dose of benzodiazepine agonists.
Topics: Animals; Benzodiazepines; Diazepam; Dizocilpine Maleate; Ethanol; Excitatory Postsynaptic Potentials; Female; Flumazenil; GABA-A Receptor Agonists; Glutamic Acid; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Morphine; Neurons; Patch-Clamp Techniques; Pyridines; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission; Ventral Tegmental Area; Zolpidem | 2009 |
Neurotransmitters in coma, vegetative and minimally conscious states, pharmacological interventions.
Topics: Antidepressive Agents, Tricyclic; Baclofen; Coma; Dopamine Agents; GABA Agonists; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Models, Biological; Neurotransmitter Agents; Persistent Vegetative State; Pyridines; Zolpidem | 2010 |
Hypocretin/orexin antagonism enhances sleep-related adenosine and GABA neurotransmission in rat basal forebrain.
Topics: Acetamides; Adenosine; Animals; Antibodies, Monoclonal; Basal Forebrain; Butyric Acid; Cholinergic Neurons; gamma-Aminobutyric Acid; Glutamic Acid; Intracellular Signaling Peptides and Proteins; Isoquinolines; Male; Neuropeptides; Orexin Receptor Antagonists; Orexin Receptors; Orexins; Pyridines; Rats; Rats, Sprague-Dawley; Ribosome Inactivating Proteins, Type 1; Saporins; Sleep; Synaptic Transmission; Wakefulness; Zolpidem | 2016 |